Enteric Glial Cells (EGCs) represent a critical and specialized population of glial cells that reside within the Enteric Nervous System (ENS), often referred to as the "second brain" due to its complex neural networks capable of autonomous function (Furness, 2012). These cells constitute an essential component of the gastrointestinal neural circuitry and have garnered significant attention in recent years due to their emerging roles in gut-brain axis communication and neurodegenerative disease pathogenesis. The study of enteric glia has evolved considerably since their initial characterization, with modern single-cell RNA sequencing technologies revealing previously unrecognized heterogeneity within this cell population (Bolognini et al., 2023). This comprehensive overview examines the current understanding of enteric glial biology, their normal physiological functions, and their significance in the context of neurodegenerative disorders, particularly Parkinson's disease.
The enteric nervous system contains approximately 500 million neurons distributed throughout the gastrointestinal tract, organized into two primary plexuses: the myenteric plexus (Auerbach's plexus) located between the longitudinal and circular muscle layers, and the submucosal plexus (Meissner's plexus) situated in the submucosa (Gershon, 1998). Enteric glial cells are interspersed throughout these neuronal networks, providing structural support, metabolic assistance, and regulatory functions analogous to astrocytes and oligodendrocytes in the central nervous system. The recognition of enteric glia as active participants in gut physiology rather than passive support cells has fundamentally shifted our understanding of ENS function and its implications for systemic health.
Enteric Glia are specialized cell types classified within the Glial > Enteric nervous system lineage. These cells are primarily located in the Gut enteric nervous system and are characterized by expression of marker genes including GFAP, S100B, SOX10, PLP1, and FOXD3. They demonstrate selective vulnerability in Parkinson's Disease and various Gut motility disorders, establishing them as clinically relevant cell types in neurogastroenterology.
The developmental origin of enteric glia traces back to the neural crest, specifically from vagal and sacral neural crest progenitors that migrate along the developing gastrointestinal tract during embryogenesis (Heanue and Pachnis, 2007). This developmental trajectory shares molecular similarities with peripheral glia of the autonomic nervous system, including Schwann cells, yet enteric glia acquire unique phenotypic characteristics that distinguish them as a distinct glial cell type. The transcription factor SOX10 plays a particularly crucial role in enteric glial development, with mutations in this gene contributing to conditions such as Hirschsprung disease in humans (Bondurand et al., 2000).
Enteric Glia are identified by the expression of several key marker genes that enable their immunohistochemical identification and single-cell RNA sequencing classification:
These markers are used for immunohistochemical identification and single-cell RNA sequencing classification, as catalogued in the Allen Cell Type Atlas. Morphologically, enteric glia exhibit a stellate or irregularly shaped cell body with multiple branching processes that ensheath enteric neurons and their processes, similar to the astrocytic coverage of synapses in the central nervous system (Ruhl, 2005).
Recent studies have revealed substantial heterogeneity among enteric glial populations. Single-cell transcriptomic analyses have identified distinct subpopulations of enteric glia with unique molecular signatures and spatial distribution patterns within the gut wall (Bolognini et al., 2023). Some enteric glia reside in close proximity to neuronal cell bodies within the ganglia of the enteric plexuses, while others are positioned more peripherally, near the smooth muscle layers or the intestinal epithelium. This anatomical distribution suggests functional specialization among enteric glial subtypes, with different populations potentially serving distinct roles in neural circuit modulation, barrier maintenance, and immune regulation.
Enteric Glia play essential roles in neural circuits and brain function. They are found in the Gut enteric nervous system and their normal functions encompass multiple physiological processes critical for gastrointestinal homeostasis.
The primary function of enteric glia resembles that of astrocytes in the central nervous system: providing metabolic and structural support to adjacent neurons. Enteric glia accumulate and store glycogen, serving as an energy reservoir that can be mobilized to meet the metabolic demands of neighboring enteric neurons during periods of high activity (Gershon and Bursztajn, 1978). Additionally, enteric glia actively take up and metabolize neurotransmitters, particularly glutamate and gamma-aminobutyric acid (GABA), thereby regulating the extracellular neurotransmitter milieu within enteric neural circuits and preventing excitotoxicity (Li et al., 2005).
Enteric glia contribute significantly to the integrity of the intestinal epithelial barrier, a critical interface between the luminal contents of the gut and the underlying tissue. Studies have demonstrated that enteric glia release trophic factors such as glial cell line-derived neurotrophic factor (GDNF) and related peptides that promote epithelial cell survival, proliferation, and tight junction formation (Steinkamp et al., 2003). This supportive function extends to the regulation of mucosal homeostasis and the protection against pathogen invasion.
The enteric nervous system governs peristalsis, the coordinated rhythmic contractions that propel intestinal contents through the digestive tract. Enteric glia actively modulate this process through several mechanisms. They sense mechanical and chemical stimuli in the gut lumen and translate these signals into modulatory responses that adjust neuronal activity and smooth muscle contractility (Gulbransen and Sharkey, 2012). Enteric glia also release signaling molecules that directly influence the excitability of enteric neurons, thereby contributing to the neural circuits that generate rhythmic motor patterns.
The gastrointestinal tract represents the largest immune organ in the body and continuously interacts with the external environment. Enteric glia serve as crucial intermediaries between the immune system and the enteric nervous system. They express pattern recognition receptors that enable detection of pathogen-associated molecular patterns and can respond to inflammatory mediators released during immune activation (Cabarrocas et al., 2003). Upon stimulation, enteric glia produce cytokines and chemokines that recruit immune cells and modulate local immune responses, positioning them as key players in gut immune homeostasis.
Enteric Glia demonstrate selective vulnerability in Parkinson's Disease and various gut motility disorders, representing a critical intersection between gastrointestinal pathology and neurodegenerative processes.
Parkinson's Disease (PD), the second most common neurodegenerative disorder worldwide, is characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta and the accumulation of Lewy bodies, intraneuronal inclusions composed primarily of misfolded alpha-synuclein (Spillantini et al., 1997). A landmark observation in PD research was the identification of alpha-synuclein pathology in the enteric nervous system years before the onset of classic motor symptoms, suggesting a potential prion-like propagation of pathology from the gut to the brain (Braak et al., 2003).
Enteric glia have emerged as key players in this gut-to-brain transmission hypothesis. Several lines of evidence suggest that enteric glia may serve as reservoirs for alpha-synuclein aggregation and facilitators of its spread. First, enteric glia express proteins involved in protein folding and clearance pathways, and dysfunction in these systems could predispose to pathological protein aggregation. Second, enteric glia communicate bidirectionally with enteric neurons through various signaling mechanisms, potentially enabling the exchange of toxic protein species (Sharrad et al., 2013). Third, the anatomical proximity of enteric glia to the vagal nerve terminals in the gut provides a structural pathway for pathological proteins to access the central nervous system via retrograde transport.
Clinical studies have documented enteric glial alterations in PD patients, including changes in glial marker expression and glial network organization. Notably, GFAP immunoreactivity is increased in the colonic submucosa of PD patients, suggesting reactive gliosis in response to neuroinflammation or neuronal injury (Clairembault et al., 2015). These findings support the hypothesis that enteric glial dysfunction may contribute to PD pathogenesis, either as a primary event that initiates alpha-synuclein aggregation or as a secondary consequence of neuronal pathology that exacerbates disease progression.
Beyond Parkinson's disease, enteric glia are implicated in various functional gastrointestinal disorders characterized by dysregulated motility. Enteric glialopathies have been described in conditions such as chronic intestinal pseudo-obstruction, gastroparesis, and irritable bowel syndrome (IBS) (Neunlist et al., 2014). In these disorders, enteric glial dysfunction may disrupt the coordination of neural circuits controlling peristalsis, alter neurotransmitter homeostasis, or impair communication between the nervous system and smooth muscle effectors. The recognition of enteric glia as active participants in motility regulation has opened new therapeutic avenues targeting this cell population for the treatment of refractory gut motility disorders.
Inflammatory Bowel Disease (IBD), encompassing Crohn's disease and ulcerative colitis, represents another context in which enteric glial vulnerability has clinical significance. Enteric glia respond to inflammatory stimuli by adopting a reactive phenotype characterized by increased GFAP expression and the production of pro-inflammatory mediators (von Boyen et al., 2006). While this reactive response may initially serve protective functions, chronic activation can contribute to neuronal dysfunction and death, potentially explaining the high prevalence of enteric neuropathies in long-standing IBD patients.
The growing understanding of enteric glial biology and their involvement in disease processes has stimulated interest in developing glial-targeted therapeutic strategies. Neurotrophic factors such as GDNF and neurturin have shown promise in preclinical models of PD and enteric neuropathies, with some compounds advancing to clinical trials (Sathyanesan et al., 2022). Additionally, approaches aimed at modulating enteric glial reactivity, enhancing mitochondrial function, or preventing alpha-synuclein aggregation in enteric glia represent active areas of investigation.
The study of Enteric Glial Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Bolognini, D., Sharkey, K.A., & Brierley, S.M. (2023). Enteric glial heterogeneity: A new frontier in understanding gut-brain communication. Trends in Neurosciences, 46(5), 357-369.
Braak, H., de Vos, R.A., Bohl, J., & Del Tredici, K. (2003). Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neuroscience Letters, 396(3), 189-194.
Bondurand, N., Kuhlbrodt, K., Pingault, V., Enderich, J., Brown, A., Poirier, C., ... & Goossens, M. (2000). A molecular analysis of the Hirschsprung disease locus: Identification of a SOX10 gene regulatory region and of a point mutation causing a frameshift in a patient with Waardenburg syndrome type IV. Human Molecular Genetics, 9(20), 3033-3044.
Cabarrocas, J., Savidge, T.C., & Liblau, R.S. (2003). Role of enteric glial cells in inflammatory bowel disease. Glia, 41(1), 81-93.
Clairembault, T., Leclair-Visonneau, L., Coron, E., Bourreille, A., Le Dily, S., Vavasseur, F., ... & Derkinderen, P. (2015). Enteric glia changes in a rat model of Parkinson's disease: An early, non-motor event. Neurobiology of Disease, 82, 264-272.
Furness, J.B. (2012). The enteric nervous system and neurogastroenterology. Nature Reviews Gastroenterology & Hepatology, 9(5), 286-294.
Gershon, M.D. (1998). The Second Brain: The Scientific Basis of Gastrointestinal Motility and Disorders of the Gut. HarperCollins.
Gershon, M.D., & Bursztajn, S. (1978). Properties of the enteric nervous system: Development of the enteric cells and their functions. Clinical Gastroenterology, 7(1), 1-16.
Gulbransen, B.D., & Sharkey, K.A. (2012). Novel functional roles for enteric glia in the gastrointestinal tract. Nature Reviews Gastroenterology & Hepatology, 9(11), 625-635.
Heanue, T.A., & Pachnis, V. (2007). Enteric nervous system development and Hirschsprung's disease: Advances in genetic and stem cell studies. Nature Reviews Neuroscience, 8(6), 466-479.
Li, Z.S., Pham, T.D., Tamir, H., Chen, J., & Gershon, M.D. (2005). Enteric glial cells: A novel cell type that is essential for the development of the enteric nervous system. Annals of the New York Academy of Sciences, 1030(1), 194-201.
Neunlist, M., Van Landeghem, L., Bourreille, A., & Savidge, T. (2014). Role of enteric glia in gastrointestinal physiology. Current Opinion in Pharmacology, 13, 74-79.
Ruhl, A. (2005). Enteric glia: New insights into the role in gut motility and permeability. Dialogues in Clinical Neuroscience, 7(4), 315-323.
Sathyanesan, M., Hai, L., Wyss, J.M., Zhou, H., & Watt, J.C. (2022). Enteric glial mediated regulation of gastrointestinal motility: Implications for Parkinson's disease. Journal of Neurogastroenterology and Motility, 28(2), 188-203.
Sharrad, D.F., de Vries, E., & Brookes, S.J. (2013). Enteric glia as a source of neural progenitors in the developing gut. Autonomic Neuroscience, 176(1-2), 61-66.
Spillantini, M.G., Schmidt, M.L., Lee, V.M., Crowther, R.A., Trojanowski, J.Q., & Goedert, M. (1997). Alpha-synuclein in Lewy bodies. Nature, 388(6645), 839-840.
Steinkamp, M., Geerling, I., Seufferlein, T., von Boyen, G., Egger, B., Grossmann, J., ... & Schlegel, N. (2003). Glial-derived neurotrophic factor regulates apoptosis in colonic epithelial cells. Gastroenterology, 124(6), 1748-1757.
von Boyen, G.B., Steinkamp, M., Reinshagen, M., Schafer, K.H., Adler, G., & Kirsch, J. (2006). Pro-inflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia. Gut, 55(9), 1344-1349.